Thus, the P2RX7 upregulation in dystrophic muscle cells might be an attempt to reprogram cell metabolism to meet the needs imposed by intrinsic metabolic abnormalities observed in DMD (Sharma et al. 2003) and/or adverse dystrophic muscle environment (reactive oxygen species, inflammation). The gene discussed is P2RX7; the disease is Duchenne muscular dystrophy.